Lupus is a chronic disease for which there is currently no cure, with patients suffering with a lot of misconceptions and misunderstandings. Along with physicians, patients are the best people to discuss the disease, as is the case with Ellarea Maria Cole Stansbury, the author of the recently published book “…
Raanana, Israel based XTL Biopharmaceuticals Ltd. (XTL)Â has announced that following evaluation of market opportunity for its pipeline products its decision to focus efforts and expenditures exclusively on two core assets: hCDR1 for treatment of SLE/lupus and rHuEPO for “no-option” multiple myeloma patients. XTL, whose shares are traded on the…
A new study recently published in the journal Annals of the Rheumatic Diseases revealed the results of a Phase II trial assessing the use of the investigational therapeutic agent rontalizumab (rhuMAb interferon-alpha) in patients with systemic lupus erythematosus (SLE). The study was conducted by researchers at the…
A group of national bestselling authors gathered last Saturday to discuss the best ways to manage lupus at an event organized by the Lupus Foundation of America, Florida Chapter (LFAFL), which took place at the Nova Southeastern University, Orlando, Florida. The series of programs intended to improve knowledge on this autoimmune and…
A study led by researchers at the University of Michigan revealed that lupus nephritis can be linked to a specific DNA modification pattern in patients. The study was recently published in the Journal of Autoimmunity and is entitled “Renal involvement in lupus is…
The Lupus Foundation of America has recently launched the KNOW LUPUS campaign to raise awareness and funding to support patients with lupus, as well as research to cure the disease. The first positive result of the campaign was found during the filming of its public…
The prestigious 2015 Lupus Insight Prize was awarded to investigator George C. Tsokos, MD, who serves as chief of the Rheumatology Division at Beth Israel Deaconess Medical Center as well as professor of Medicine at Harvard Medical School. Dr. Tsokos was selected by the Alliance for…
The Lupus Research Institute and the S.L.E. Lupus Foundation are two of the over 200 patient organizations that are part of the “I Am (Still) Essential” coalition, which has recently advocated for changes in the Essential Health Benefits for 2016 with the U.S. Department of Health and Human Services (HHS). The organizations believe…
Representatives of Lupus Agencies of New York State, the S.L.E. Lupus Foundation and Lupus Research Institute recently joined together at the New York State Capitol to raise awareness about the disease on Annual Lupus Awareness Day, last Wednesday, May 13th. The state of New York is celebrating May as …
Thousands of children and young people in the United States struggle with lupus. The treatment of the condition requires more aggressive drugs than for adult patients and the adverse effects of the drugs impact biological, psychological, and social development. To study the issue, a team of researchers at the Children’s Hospital…